All Stories

  1. Carotid Plaque Burden Is a Stronger Predictor of Cardiovascular Risk Than IMT
  2. Vertebrobasilar ischemia: Some less recognized aspects
  3. Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences
  4. Homocysteine and Thrombophilia in Pulmonary Hypertension
  5. Cardiovascular effects of TMAO and other toxic metabolites of the intestinal microbiome
  6. Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension
  7. In Memoriam: Jim Toole, MD: Ahead of His Time
  8. B vitamins for NASH: use methylcobalamin, not cyanocobalamin
  9. Problem in the Recent American Heart Association Guideline on Secondary Stroke Prevention: B Vitamins to Lower Homocysteine Do Prevent Stroke
  10. Identifying High-Risk Nonstenotic Carotid Artery Disease
  11. Management of Patients with Embolic Stroke of Unknown Source: Interpreting the Evidence in the Light of Clinical Judgement
  12. Efficacy of Lower Doses of Pioglitazone after Stroke or Transient Ischemic Attack In Patients with Insulin Resistance
  13. Fasting lipids are not a good way to assess the effects of diet on cardiovascular risk
  14. How to identify which patients should not have a systolic blood pressure target of <120 mmHg
  15. Deep Learning-Based Measurement of Total Plaque Area in B-Mode Ultrasound Images
  16. Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement
  17. CONNed in Pregnancy
  18. Physiological Treatment of Hypertension in Black Patients: Time for Action
  19. Sex differences in the intestinal microbiome: interactions with risk factors for atherosclerosis and cardiovascular disease
  20. Triglyceride/High‐Density Lipoprotein Cholesterol Ratio: A Clue to Metabolic Syndrome, Insulin Resistance, and Severe Atherosclerosis
  21. Renovascular Hypertension
  22. Cardiovascular Harm From Egg Yolk and Meat: More Than Just Cholesterol and Saturated Fat
  23. It's time to stop the nonsense of withholding lipid lowering therapy on account of age
  24. Measurement of carotid plaque burden: A tool for predicting and preventing dementia?
  25. Stroke Prevention: Little-Known and Neglected Aspects
  26. Reducing the Risk of Stroke in Patients with Impaired Renal Function: Nutritional Issues
  27. Stroke Prevention in Older Adults
  28. A Voxel-Based Fully Convolution Network and Continuous Max-Flow for Carotid Vessel-Wall-Volume Segmentation From 3D Ultrasound Images
  29. IMT is not atherosclerosis
  30. China Stroke Statistics 2019: a wealth of opportunities for stroke prevention
  31. Recent advances in preventing recurrent stroke
  32. New Canadian guideline is wrong to say acetylsalicylic acid is only for patients with symptomatic vascular disease
  33. Achieving blood pressure control targets in hypertensive patients of rural China – a pilot randomized trial
  34. Risk from low blood pressure in frail older adults: diastolic pressure and pulse pressure are important
  35. Stroke Prevention
  36. Interaction of smoking, hyperhomocysteinemia and metabolic syndrome with carotid atherosclerosis: A cross sectional study in 972 non-diabetic patients
  37. Traffic‐Related Air Pollution and Carotid Plaque Burden in a Canadian City With Low‐Level Ambient Pollution
  38. Impaired Renal Function and Cerebrovascular Disease
  39. Triglyceride lowering drugs: not just icosapent ethyl
  40. Adding Insight to Injury!
  41. Effect of Vitamin B12 Levels on the Association Between Folic Acid Treatment and CKD Progression: A Post Hoc Analysis of a Folic Acid Interventional Trial
  42. Lower risk of stroke with a vegetarian diet
  43. Choosing the right therapy for a patient with asymptomatic carotid stenosis
  44. Patent foramen ovale in patients with atrial fibrillation
  45. Three-dimensional ultrasound evaluation of the effects of pomegranate therapy on carotid plaque texture using locality preserving projection
  46. Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke
  47. Rationale for screening selected patients for asymptomatic carotid artery stenosis
  48. Asymptomatic Carotid Stenosis: High Risk With Suboptimal Treatment
  49. Longitudinal assessment of carotid plaque texture in three-dimensional ultrasound images based on semi-supervised graph-based dimensionality reduction and feature selection
  50. Mechanisms of Stroke in COVID-19
  51. The need for clinical judgement in the application of evidence-based medicine
  52. Chili Pepper Consumption and Cardiovascular Mortality
  53. Resistant Hypertension
  54. Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017
  55. Trimethylamine N-oxide: not just red meat—egg yolk and renal function are also important
  56. Carotid Intima–Media Thickness Versus Carotid Plaque Burden for Predicting Cardiovascular Risk
  57. Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs
  58. Registration of amiloride in South Africa: Cutting the Gordian knot
  59. Statins for Primary Prevention of Cardiovascular Disease
  60. Deep learning‐based carotid media‐adventitia and lumen‐intima boundary segmentation from three‐dimensional ultrasound images
  61. Coronary calcium is not all we need: Carotid plaque burden measured by ultrasound is better
  62. Periprocedural events dominate outcomes of carotid stenting and endarterectomy
  63. Nutrition and Risk of Stroke
  64. The Importance of Blood Pressure Gradients in the Brain
  65. Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack
  66. Pioglitazone Therapy in Patients With Stroke and Prediabetes
  67. Blood Pressure Gradients in the Brain: Their Importance to Understanding Pathogenesis of Cerebral Small Vessel Disease
  68. Anticoagulation in patients with Embolic Stroke of Unknown Source
  69. Vitamin B12 deficiency and hyperhomocysteinaemia in outpatients with stroke or transient ischaemic attack: a cohort study at an academic medical centre
  70. Increased carotid plaque burden in patients with family medical history of premature cardiovascular events in the absence of classical risk factors
  71. Hypertension in Africa
  72. Decline in the Severity of Carotid Atherosclerosis and Associated Risk Factors From 2002 to 2014
  73. Harm With High Levels of Serum B12 in Elderly Persons
  74. Cardiovascular benefit of egg consumption is most unlikely
  75. Advances in Stroke Prevention
  76. Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden
  77. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
  78. Data on the gut and saliva microbiota from a cohort of atherosclerosis patients determined by 16S rRNA gene sequencing
  79. Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications
  80. Hypertension in Blacks
  81. Fractal dimension based carotid plaque characterization from three-dimensional ultrasound images
  82. Mediterranean Diet Score: Associations with Metabolic Products of the Intestinal Microbiome, Carotid Plaque Burden, and Renal Function
  83. Stroke Prevention: Editorial to accompany June issue of SVN
  84. [18F]-Fluorodeoxyglucose PET/CT imaging as a marker of carotid plaque inflammation: Comparison to immunohistology and relationship to acuity of events
  85. Egg Consumption and Cardiovascular Risk
  86. Supplemental Vitamins and Minerals for CVD Prevention and Treatment
  87. Metabolic products of the intestinal microbiome and extremes of atherosclerosis
  88. Diastolic J curve, cuff artefact and low targets for SBP
  89. Problems with polypills
  90. The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension
  91. B Vitamins for Stroke Prevention
  92. Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position
  93. Cardioembolic stroke: everything has changed
  94. Controlling resistant hypertension
  95. How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting
  96. Effect of wine on carotid atherosclerosis in type 2 diabetes: a 2-year randomized controlled trial
  97. Diet for stroke prevention
  98. Letter by Spence Regarding Article, “Serum Potassium Is Positively Associated With Stroke and Mortality in the Large, Population-Based Malmö Preventive Project Cohort”
  99. Homocysteine Lowering with B Vitamins for Stroke Prevention—A History
  100. Hypertension in US-born vs. foreign-born African-Americans
  101. Association of homocysteine and smoking with cerebral microemboli in patients with mechanical heart valves: a transcranial Doppler study
  102. Letter by Spence Regarding Article, “Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis”
  103. Systolic blood pressure targets, diastolic J curve and cuff artefact in blood pressure measurement: a note of caution
  104. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
  105. Smoking cessation and outcome after ischemic stroke or TIA
  106. B vitamins in stroke prevention: time to reconsider
  107. Sensitive three-dimensional ultrasound assessment of carotid atherosclerosis by weighted average of local vessel wall and plaque thickness change
  108. Motor recovery beginning 23 years after ischemic stroke
  109. Cuff Artifact, J Curve, and Application of Hypertension Guidelines in the Elderly
  110. Approaching Automated 3-Dimensional Measurement of Atherosclerotic Plaque Volume ∗
  111. Recent advances in preventing stroke recurrence
  112. Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease
  113. Nutrition in Stroke Prevention
  114. Resistant Atherosclerosis
  115. Physiological Phenotyping for Personalized Therapy of Uncontrolled Hypertension in Africa
  116. Rational Medical Therapy Is the Key to Effective Cardiovascular Disease Prevention
  117. Asymptomatic carotid stenosis
  118. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
  119. [ 18 F]-NaF PET/CT Identifies Active Calcification in Carotid Plaque
  120. 3D Ultrasound for Imaging and Quantifying Carotid Ulcers
  121. Diastolic Hypotension and Myocardial Ischemia
  122. Transcranial Doppler monitoring for microemboli: a marker of a high-risk carotid plaque
  123. Carotid plaque burden is associated with higher levels of total homocysteine
  124. CADASIL accelerated by acute hypotension
  125. Hypertension in blacks
  126. High Frequency of Variants of Candidate Genes in Black Africans with Low Renin-Resistant Hypertension
  127. Effects of eplerenone on resistance to antihypertensive medication in patients with primary or secondary hyperaldosteronism
  128. Increased Coagulation With Aging: Importance of Homocysteine and Vitamin B12
  129. Henry J.M. Barnett
  130. Determinants of carotid plaque burden
  131. Folic acid supplementation and chronic kidney disease progression
  132. Re: ‘Transcranial Doppler Ultrasound Detection of Microemboli as a Predictor of Cerebral Events in Patients with Symptomatic and Asymptomatic Carotid Disease: A Systematic Review and Meta-Analysis’
  133. Intestinal Microbiome and Atherosclerosis
  134. Statins probably do not cause cataracts
  135. Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients
  136. Editorial: Time for Earlier and More Intensive Preventive Therapy
  137. Latest Skirmishes in the Long-Term Battle Between Carotid Endarterectomy and Stenting
  138. Cryptogenic Stroke
  139. Taking care of volunteers in a stroke trial: a new assisted-management strategy
  140. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest
  141. Transcranial Doppler is Complementary to Echocardiography for Detection and Risk Stratification of Patent Foramen Ovale
  142. Homocysteine lowering for stroke prevention: Unravelling the complexity of the evidence
  143. Recent advances in pathogenesis, assessment, and treatment of atherosclerosis
  144. Transcranial Doppler Emboli Identifies Asymptomatic Carotid Patients at High Stroke Risk: Why This Technique Should be Used More Widely
  145. Strategies for improving blood pressure control in Africa
  146. Appropriate management of asymptomatic carotid stenosis
  147. Endarterectomy vs. stenting vs. medical therapy
  148. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
  149. Endarterectomy, Stenting, or Neither for Asymptomatic Carotid-Artery Stenosis
  150. Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke
  151. Plaque Assessment in the Management of Patients with Asymptomatic Carotid Stenosis
  152. Three-Dimensional Ultrasound of Carotid Plaque
  153. Overcoming Challenges With Statin Therapy
  154. Dietary cholesterol and egg yolk should be avoided by patients at risk of vascular disease
  155. Adding carotid total plaque area to the Framingham risk score improves cardiovascular risk classification
  156. Hypertension and Stroke
  157. Definition of Best Medical Treatment in Asymptomatic and Symptomatic Carotid Artery Stenosis
  158. Management of Patients with an Asymptomatic Carotid Stenosis—Medical Management, Endovascular Treatment, or Carotid Endarterectomy?
  159. Transcranial Doppler: Uses in Stroke Prevention
  160. Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine
  161. J Curve and Cuff Artefact, and Diagnostic Inertia in Resistant Hypertension
  162. Risk of Stroke at the Time of Carotid Occlusion
  163. Review and prioritization of stroke research recommendations to address the mission of the World Stroke Organization: a call to action from the WSO Research Committee
  164. Carotid Ultrasound Phenotypes Are Biologically Distinct
  165. Letter by Spence Regarding Article, “Diet and Stroke: Recent Evidence Supporting a Mediterranean-Style Diet and Food in the Primary Prevention of Stroke”
  166. Importance of sex and gender in atherosclerosis and cardiovascular disease
  167. 3D carotid reconstructions: imaging, pathology, algorithms and pipelines
  168. Blood Pressure Control in Canada: The View From a Stroke Prevention Clinic
  169. Dilemmas in Diagnosing and Managing Hypertension: Is White Coat Hypertension Benign?
  170. Management of Asymptomatic Carotid Stenosis
  171. Statins and Cataracts: Reverse Causality?
  172. Recent advances in atrial fibrillation and stroke
  173. Aspirin for Prevention of Cardiovascular Events in Older Japanese Patients
  174. Letter by Spence Regarding Article, "Differential Effect of B-Vitamin Therapy by Antiplatelet Use on Risk of Recurrent Vascular Events After Stroke"
  175. Measurement of Carotid Plaque Burden
  176. Management of resistant hypertension
  177. Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke: Results From the EMBRACE Trial
  178. Are some diets "mass murder"? Mediterranean diet is not to blame for increased carbohydrate intake
  179. Statins and Intracerebral Hemorrhage
  180. The 99mTc-DTPA Urinary Clearance Method May Be Preferable to the Plasma Disappearance Method for Assessing Glomerular Filtration Rate in Diabetic Nephropathy
  181. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: Rationale and design of the Insulin Resistance Intervention after Stroke Trial
  182. Risk of Vascular Disease in Premenopausal Women With Diabetes Mellitus
  183. Identifying Which Patients With Asymptomatic Carotid Stenosis Could Benefit From Intervention: Table.
  184. Recurrent Stroke and Patent Foramen Ovale
  185. Cryptogenic Stroke and Atrial Fibrillation
  186. Secular Trends in Ischemic Stroke Subtypes and Stroke Risk Factors
  187. Statins and Ischemic Stroke
  188. How far to lower blood pressure in the long term, after a stroke?
  189. Time course of atherosclerosis regression
  190. Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies
  191. Three-Dimensional Carotid Ultrasound Plaque Texture Predicts Vascular Events
  192. Arterial age as a substitute for chronological age in the AGLA risk function could improve coronary risk prediction
  193. Atrial Fibrillation in Patients with Cryptogenic Stroke
  194. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals
  195. Pulmonary Abnormalities and Carotid Atherosclerosis in Ex-Smokers without Airflow Limitation
  196. A Single Fixed-Dose Combination for All Patients Is Bad Medicine
  197. Volume of Carotid Artery Ulceration as a Predictor of Cardiovascular Events
  198. Microhabitat Use in a Northern Peripheral Population ofApodemia mormo: Factors Beyond the Host Plant
  199. Free fatty acids to predict recurrent ischemic stroke
  200. Effects of the Intestinal Microbiome on Constituents of Red Meat and Egg Yolks: A New Window Opens on Nutrition and Cardiovascular Disease
  201. SPARKLE (Subtypes of Ischaemic Stroke Classification System), Incorporating Measurement of Carotid Plaque Burden: A New Validated Tool for the Classification of Ischemic Stroke Subtypes
  202. Carotid Stenosis
  203. Egg consumption and coronary disease: Letter to the editor regarding Chagas P, Caramori P, Galdino TP, Barcellos CS, Gomes I, Schwanke CH. Egg consumption and coronary atherosclerotic burden. Atherosclerosis 2013 August;229(2):381–4
  204. Trust between specialists and family physicians
  205. One, two and three-dimensional ultrasound measurements of carotid atherosclerosis before and after cardiac rehabilitation: preliminary results of a randomized controlled trial
  206. Intensive risk factor control in stroke prevention
  207. Retinal Vasculature: A Window on the Brain
  208. Barometer in the Storm—Carotid Artery Plaque Quantified by Three-Dimensional Ultrasound
  209. Treatment of Renal Artery Stenosis
  210. Progression of Carotid Plaque Volume Predicts Cardiovascular Events
  211. Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
  212. Why Calls for More Routine Carotid Stenting Are Currently Inappropriate: An International, Multispecialty, Expert Review and Position Statement
  213. Egg yolk consumption, smoking and carotid plaque: Reply to letters to the Editor by Sean Lucan and T Dylan Olver et al.
  214. Atherosclerosis Imaging and the Canadian Atherosclerosis Imaging Network
  215. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals
  216. Migraine, Shear Stress, and Platelet Serotonin
  217. Diabetes, Intracranial Stenosis and Microemboli in Asymptomatic Carotid Stenosis
  218. Asymptomatic Carotid Stenosis
  219. Blood pressure and opera
  220. Ultrasonographic Measure of Carotid Plaque Burden
  221. B vitamin therapy for homocysteine: renal function and vitamin B12 determine cardiovascular outcomes
  222. Antihypertensive treatment can prevent stroke and cognitive decline
  223. Atrial fibrillation and stroke prevention: is warfarin still an option? Yes
  224. Effects of Aldosterone on Human Atherosclerosis: Plasma Aldosterone and Progression of Carotid Plaque
  225. Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: What Leonardo da Vinci could not see
  226. Egg yolk consumption and carotid plaque
  227. Premature Atherosclerosis Is Associated With Hypovitaminosis D and Angiotensin-Converting Enzyme Inhibitor Non-use in Lupus Patients
  228. Letter to the Editor: The ezetimibe ‘controversy' is a misunderstanding
  229. Albuminuria and risk of stroke in African Americans: A marker of uncontrolled hypertension?
  230. Statins do not cause intracerebral hemorrhage
  231. Genetics of atherosclerosis: The power of plaque burden and progression
  232. Mechanisms of Lipoprotein(a) Pathogenicity: Prothrombotic, Proatherosclerotic, or Both?
  233. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
  234. Lessons From Africa: The Importance of Measuring Plasma Renin and Aldosterone in Resistant Hypertension
  235. Why the US Center for Medicare and Medicaid Services Should Not Extend Reimbursement Indications for Carotid Artery Angioplasty/Stenting
  236. Pseudohypertension
  237. Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting
  238. Why the United States Center for Medicare and Medicaid Services (CMS) Should not Extend Reimbursement Indications for Carotid Artery Angioplasty/Stenting
  239. Identifying high-risk asymptomatic carotid stenosis
  240. Why the United States Center for Medicare and Medicaid Services should not extend reimbursement indications for carotid artery angioplasty/stenting
  241. Ezetimibe and Regression of Carotid Atherosclerosis
  242. Carotid plaque measurement is superior to IMT
  243. Understanding the Complexity of Homocysteine Lowering With Vitamins
  244. High-risk asymptomatic carotid stenosis: Ulceration on 3D ultrasound vs TCD microemboli
  245. Short-acting nifedipine and risk of stroke
  246. New and Emerging Weight Management Strategies for Busy Ambulatory Settings: A Scientific Statement From the American Heart Association * Endorsed by the Society of Behavioral Medicine
  247. Asymptomatic Carotid Stenosis: Identifying Patients at High Enough Risk to Warrant Endarterectomy or Stenting
  248. Influence of Noninvasive Cardiovascular Imaging in Primary Prevention
  249. Reply to Letters from Dr Maria Luz Fernandez, Eddie Vos, and Dr Niva Shapira
  250. Toward Clinical Applications of Carotid Ultrasound: Intima-Media Thickness, Plaque Area, and Three-Dimensional Phenotypes
  251. Carotid Plaque Surface Irregularity
  252. Volumetric Evaluation of Carotid Atherosclerosis Using 3-Dimensional Ultrasonic Imaging
  253. Response to Letter by Hadjiev et al
  254. 3D Carotid Ultrasound Imaging
  255. Clinical Clues to Paradoxical Embolism
  256. Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific MortalityMeta-analysis of 8 Randomized Trials Involving 37 485 IndividualsEffects of Lowering Homocysteine Lev...
  257. Is there a role for revascularisation in asymptomatic carotid stenosis? No
  258. Is there a role for revascularisation in asymptomatic carotid stenosis? Yes
  259. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
  260. B-Vitamin Therapy for Diabetic Nephropathy—Reply
  261. Secondary stroke prevention
  262. Identifying high-risk patients from carotid plaque composition
  263. Asymptomatic Carotid Stenosis: Mainly a Medical Condition
  264. Physiologic Tailoring of Treatment in Resistant Hypertension
  265. Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy
  266. Treating Arteries Instead of Risk Factors: A Paradigm Change in Management of Atherosclerosis
  267. Extremes of Unexplained Variation as a Phenotype: An Efficient Approach for Genome-Wide Association Studies of Cardiovascular Disease
  268. Three-dimensional ultrasound-based texture analysis of the effect of atorvastatin on carotid atherosclerosis
  269. Dietary Intervention to Reverse Carotid Atherosclerosis
  270. The role of lipoprotein(a) in the formation of arterial plaques, stenoses and occlusions
  271. Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics
  272. Effects of Intensive Medical Therapy on Microemboli and Cardiovascular Risk in Asymptomatic Carotid Stenosis
  273. Three-Dimensional Carotid Ultrasound Segmentation Variability Dependence on Signal Difference and Boundary Orientation
  274. Three-dimensional Ultrasound Quantification of Intensive Statin Treatment of Carotid Atherosclerosis
  275. Treating Hypertension in Acute Ischemic Stroke
  276. Atrial fibrillation, stroke prevention therapy and aging
  277. Longitudinal Ultrasound Evaluation of Carotid Atherosclerosis in One, Two and Three Dimensions
  278. Mechanisms of thrombogenesis in atrial fibrillation
  279. Analysis of carotid lumen surface morphology using three-dimensional ultrasound imaging
  280. Nonrigid registration of three-dimensional ultrasound and magnetic resonance images of the carotid arteries
  281. Carotid Atherosclerosis and a Reduced Likelihood for Lowered Cognitive Performance in a Canadian First Nations Population
  282. Diagnosis of primary aldosteronism: for medical management, not just surgery
  283. Mesna for the Treatment of Hyperhomocysteinemia in Hemodialysis Patients
  284. Area-preserving flattening maps of 3D ultrasound carotid arteries images
  285. Cryptogenic stroke and patent foramen ovale: Clinical clues to paradoxical embolism
  286. Scan–rescan and intra-observer variability of magnetic resonance imaging of carotid atherosclerosis at 1.5 T and 3.0 T
  287. Is Carotid Intima-Media Thickness a Reliable Clinical Predictor?
  288. A “Twisting and Bending” Model-Based Nonrigid Image Registration Technique for 3-D Ultrasound Carotid Images
  289. Angiotensin inhibition in renovascular disease: A population-based cohort study
  290. The importance of distinguishing between diffuse carotid intima-media thickening and focal plaque
  291. Quantification of carotid vessel wall and plaque thickness change using 3D ultrasound images
  292. Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area
  293. Geometry of the Carotid Bifurcation Predicts Its Exposure to Disturbed Flow
  294. Intra-Arterial Thrombolysis of Occluded Middle Cerebral Artery by Use of Collateral Pathways in Patients with Tandem Cervical Carotid Artery/Middle Cerebral Artery Occlusion
  295. Cerebrovascular events on awakening, patent foramen ovale and obstructive sleep apnea syndrome
  296. Polypill: For Pollyanna*
  297. Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
  298. White-Coat Hypertension Is Hypertension
  299. Nonrigid registration of carotid ultrasound and MR images using a "twisting and bending" model
  300. APPENDIX A: Carotid Endarterectomy-An Evidence-Based Review
  301. Mapping Spatial and Temporal Changes in Carotid Atherosclerosis from Three-Dimensional Ultrasound Images
  302. Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension
  303. Homocysteine-lowering therapy: a role in stroke prevention?
  304. Letter by Rundek et al Regarding Article, "Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis"
  305. Mesna as a Nonvitamin Intervention to Lower Plasma Total Homocysteine Concentration: Implications for Assessment of the Homocysteine Theory of Atherosclerosis
  306. Stroke prevention in the high-risk patient
  307. Plasma total homocysteine in acute stroke
  308. SU-EE-A4-01: Development of Cardiac-Gated 3-Dimensional Ultrasound Imaging of Carotid Atherosclerosis
  309. Validation of 3D Ultrasound Vessel Wall Volume: An Imaging Phenotype of Carotid Atherosclerosis
  310. New treatment options for hypertension during acute ischemic or hemorrhagic stroke
  311. Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study
  312. Manual planimetric measurement of carotid plaque volume using three-dimensional ultrasound imaging
  313. Effects of non-steroidal anti-inflammatory drugs on blood pressure
  314. Hypertension Due to Central Nervous System Dysfunction
  315. Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions
  316. Perspective on the efficacy analysis of the Vitamin Intervention for Stroke Prevention trial
  317. The Effect of Mesna on Plasma Total Homocysteine Concentration in Hemodialysis Patients
  318. 3D ultrasound analysis of carotid plaque volume and surface morphology
  319. Carotid ultrasound phenotypes in vulnerable populations
  320. Homocysteine and Stroke Prevention: Have the Trials Settled the Issue?
  321. Measurement of Intima-Media Thickness vs. Carotid Plaque: Uses in Patient Care, Genetic Research and Evaluation of New Therapies
  322. Technology Insight: ultrasound measurement of carotid plaque—patient management, genetic research and therapy evaluation
  323. A Non-Rigid Image Registration Technique for 3D Ultrasound Carotid Images using a "Twisting and Bending" Model
  324. Measuring Effects of Antiatherosclerotic Therapies
  325. Quantification of progression and regression of carotid vessel atherosclerosis using 3D ultrasound images
  326. Thiol exchange: An in vitro assay that predicts the efficacy of novel homocysteine lowering therapies
  327. Nutrition and Stroke Prevention
  328. Relationship of the metabolic syndrome to carotid ultrasound traits
  329. Po-Thur Eve General-20: A Novel Non-Invasive 3D Ultrasound Imaging Phenotype of Carotid Atherosclerosis
  330. Po-Thur Eve General-24: Non-Invasive Imaging Phenotypes of Carotid Atherosclerosis in Subjects: MRI, B-mode and 3D Ultrasound Measurements
  331. Treating Hypertension in Acute Stroke: A Better Arrow for the Quiver
  332. Lipoprotein(a): Involved in Events, but Not Burden of Atherosclerotic Disease?
  333. Folate supplementation and cardiovascular disease
  334. Quantification of carotid vessel atherosclerosis
  335. Letter to the Editor: Individualized Therapy for Hypertension
  336. Homocysteine: Call Off the Funeral
  337. 3D Ultrasound System for Analysis of Carotid Plaque Progression and Regression
  338. Tutorial in Biostatistics: Analyzing Associations between Total Plasma Homocysteine and B Vitamins Using Optimal Categorization and Segmented Regression
  339. Disparate Associations of a Functional Promoter Polymorphism in PCK1 With Carotid Wall Ultrasound Traits
  340. Vitamin Intervention for Stroke Prevention Trial: An Efficacy Analysis
  341. Absence of Microemboli on Transcranial Doppler Identifies Low-Risk Patients With Asymptomatic Carotid Stenosis
  342. Variation in the Carotid Bifurcation Geometry of Young Versus Older Adults: Implications for Geometric Risk of Atherosclerosis
  343. Erratum to “Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions” [Atherosclerosis 178(2) (2005) 319–325]
  344. Carotid endarterectomy--An evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
  345. 3D Ultrasound Measurement of Change in Carotid Plaque Volume: A Tool for Rapid Evaluation of New Therapies
  346. Complications of Type 2 Diabetes Among Aboriginal Canadians: Prevalence and associated risk factors
  347. A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes
  348. Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products
  349. Quantification of carotid plaque volume measurements using 3D ultrasound imaging
  350. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions
  351. Anthropometric data for magnetic resonance imaging of the carotid bifurcation
  352. Carotid Ultrasound in One, Two and Three Dimensions
  353. Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: A placebo-controlled, double-blind, randomized trial
  354. The current epidemic of primary aldosteronism
  355. Carotid intima-media thickness and cognitive decline: what does it mean for prevention of dementia?
  356. Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor   Associated With Carotid Atherosclerosis
  357. Non-Invasive Assessment of Atherosclerosis Risk
  358. 3D Ultrasound Imaging of the Carotid Arteries
  359. Preventing Dementia by Treating Hypertension and Preventing Stroke
  360. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration
  361. Measurement of Carotid Plaque Volume by 3-Dimensional Ultrasound
  362. Noninvasive Phenotypes of Atherosclerosis: Similar Windows but Different Views
  363. Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
  364. Sex Differences in Carotid Plaque and Stenosis
  365. The Effect of Flax Seed Cultivars with Differing Content of α-Linolenic Acid and Lignans on Responses to Mental Stress
  366. Relationship Between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease
  367. Lipoprotein Lipase (LPL) Gene Variation and Progression of Carotid Artery Plaque
  368. Infection, Inflammation, and Atherosclerosis
  369. Measurement of Carotid Plaque and Effect of Vitamin Therapy for Total Homocysteine
  370. Carotid Plaque Area: A Tool for Targeting and Evaluating Vascular Preventive Therapy
  371. Treatment options for renovascular hypertension
  372. Grapefruit juice-drug interactions
  373. Reconstruction of carotid bifurcation hemodynamics and wall thickness using computational fluid dynamics and MRI
  374. Knowledge gaps
  375. Actual practice in hypertension: Implications for persistence with and effectiveness of therapy
  376. Endarterectomy or angioplasty for treatment of carotid stenosis?
  377. Homocyst(e)ine, nitrous oxide and atherosclerosis
  378. Improved Outcomes in Stroke Thrombolysis with Pre-specified Imaging Criteria
  379. Patients With Atherosclerotic Vascular Disease
  380. Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and Design
  381. Effect of amlodipine on hemodynamic and endocrine responses to mental stress
  382. Angiotensin II antagonists for hypertension: are there differences in efficacy?
  383. Hypocholesterolemic effects of dietary citrus juices in rabbits
  384. Management of Resistant Hypertension in Patients with Carotid Stenosis: High Prevalence of Renovascular Hypertension
  385. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L
  386. Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
  387. Contents of Related Journals
  388. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema
  389. An approach to ascertain probands with a non-traditional risk factor for carotid atherosclerosis
  390. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial
  391. Effect of Usual Doses of Folate Supplementation on Elevated Plasma Homocyst(e)ine in Hemodialysis Patients: No Difference between 1 and 5 mg Daily
  392. Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis
  393. Editorial commentary
  394. Carotid Endarterectomy Does Not Affect Long-Term Blood Pressure: Observations from the NASCET
  395. Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)
  396. Metabolism of Fibric Acid Derivatives
  397. Informing the public
  398. Pseudo-hypertension in the elderly: still hazy, after all these years
  399. Correspondence
  400. Grapefruit juice—terfenadine single-dose interaction: Magnitude, mechanism, and relevance*
  401. Psychological stress and the progression of carotid artery disease
  402. Erythromycin-felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice*
  403. The acetylcholinesterase oxime reactivator HI-6 in man: Pharmacokinetics and tolerability in combination with atropine
  404. Government guidelines for treatment of hypertension
  405. Prognosis for Patients Following a Transient Ischemic Attack With and Without a Cerebral Infarction on Brain CT
  406. Grapefruit Juice and Drugs
  407. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics
  408. Grapefruit juice–felodipine interaction: Mechanism, predictability, and effect of naringin
  409. Differences in metabolism of time-release and unmodified nicotinic acid: Explanation of the differences in hypolipidemic action?
  410. Tests for renal vascular disease
  411. Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
  412. Interaction of citrus juices with felodipine and nifedipine
  413. Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning
  414. Measurement of Atherosclerosis: Development of an Atherosclerosis Severity Index
  415. EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON CONTROL OF HYPERTENSION BY BETA-BLOCKERS AND DIURETICS
  416. Evaluation of once daily endralazine in hypertension
  417. The arthritic patient with hypertension: Selection of an NSAID
  418. Hypertension in Acute Ischemic Strokes
  419. EFFECTS OF TRIAMTERENE AND AMILORIDE ON URINARY SEDIMENT IN HYPERTENSIVE PATIENTS TAKING HYDROCHLOROTHIAZIDE
  420. Blood Pressure Measurement in the Elderly: Correlation of Arterial Stiffness with Difference Between Intra-arterial and Cuff Pressures
  421. Spectrum of benign intracranial hypertension in children and adolescents
  422. Hemodynamic modification of aortic atherosclerosis
  423. Potassium-sparing Diuretics: Interaction with Digoxin in Elderly Men
  424. Phenytoin-Theophylline Interaction
  425. Pseudohypertension in the Elderly
  426. Vitamins and antioxidants